(Q41913443)

English

Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells

scientific article published on November 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Jonathan W Uhr

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

author name string

Radu Marches

1

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

492-501

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

1 reference

https://api.crossref.org/works/10.1002%2FIJC.20378

21 January 2018

Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.20378

21 January 2018

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.20378

21 January 2018

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.20378

21 January 2018

Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.20378

21 January 2018

Identifiers

10.1002/IJC.20378

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41913443&oldid=1929709055"